Source: Rebecca Robbins and Benjamin Mueller - N.Y. Times ( Paid Registration )

Unlike some other leading vaccine candidates, the AstraZeneca offering can be quickly produced in vast quantities, will cost only a few dollars per dose and is easy to store for long periods. That could substantially expand the number of countries and people that have access to the vaccine.

Read Full Article: AstraZeneca’s vaccine easy and cheap to produce, appears effective